PharmaEssentia Corporation (LUX:261280523)

PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of EUR 4.75 billion. The enterprise value is 4.17 billion.

Market Cap	4.75B
Enterprise Value	4.17B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Aug 11, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.35%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	9.80%
Owned by Institutions (%)	9.21%
Float	254.83M

Valuation Ratios

The trailing PE ratio is 35.37 and the forward PE ratio is 20.58.

PE Ratio	35.37
Forward PE	20.58
PS Ratio	12.30
PB Ratio	5.71
P/TBV Ratio	5.76
P/FCF Ratio	56.17
P/OCF Ratio	39.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.12, with an EV/FCF ratio of 49.34.

EV / Earnings	31.07
EV / Sales	10.81
EV / EBITDA	35.12
EV / EBIT	38.22
EV / FCF	49.34

Financial Position

The company has a current ratio of 6.83, with a Debt / Equity ratio of 0.03.

Current Ratio	6.83
Quick Ratio	6.45
Debt / Equity	0.03
Debt / EBITDA	0.21
Debt / FCF	0.30
Interest Coverage	155.89

Financial Efficiency

Return on equity (ROE) is 17.21% and return on invested capital (ROIC) is 8.46%.

Return on Equity (ROE)	17.21%
Return on Assets (ROA)	7.68%
Return on Invested Capital (ROIC)	8.46%
Return on Capital Employed (ROCE)	12.80%
Revenue Per Employee	2.95M
Profits Per Employee	1.03M
Employee Count	131
Asset Turnover	0.43
Inventory Turnover	1.22

Taxes

Income Tax	-27.46M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-22.33%
50-Day Moving Average	16.78
200-Day Moving Average	17.71
Relative Strength Index (RSI)	48.17
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of EUR 386.25 million and earned 134.33 million in profits. Earnings per share was 0.36.

Revenue	386.25M
Gross Profit	344.42M
Operating Income	109.27M
Pretax Income	106.87M
Net Income	134.33M
EBITDA	112.71M
EBIT	109.27M
Earnings Per Share (EPS)	0.36

Balance Sheet

The company has 603.40 million in cash and 24.97 million in debt, giving a net cash position of 578.43 million.

Cash & Cash Equivalents	603.40M
Total Debt	24.97M
Net Cash	578.43M
Net Cash Per Share	n/a
Equity (Book Value)	831.76M
Book Value Per Share	2.50
Working Capital	640.65M

Cash Flow

In the last 12 months, operating cash flow was 120.65 million and capital expenditures -36.06 million, giving a free cash flow of 84.59 million.

Operating Cash Flow	120.65M
Capital Expenditures	-36.06M
Free Cash Flow	84.59M
FCF Per Share	n/a

Margins

Gross margin is 89.17%, with operating and profit margins of 28.29% and 34.78%.

Gross Margin	89.17%
Operating Margin	28.29%
Pretax Margin	27.67%
Profit Margin	34.78%
EBITDA Margin	29.18%
EBIT Margin	28.29%
FCF Margin	21.90%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.12%.

Dividend Per Share	0.02
Dividend Yield	0.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	7.62%
Buyback Yield	-1.35%
Shareholder Yield	-1.23%
Earnings Yield	2.83%
FCF Yield	1.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaEssentia has an Altman Z-Score of 26.07 and a Piotroski F-Score of 6.

Altman Z-Score	26.07
Piotroski F-Score	6